Stifel initiates Palvella with 'buy' rating on skin treatment prospects

ReutersMar 26, 2025 2:53 PM

Brokerage Stifel starts coverage on drug developer Palvella Therapeutics PVLA.O with "buy" rating and $45 PT

New PT represents a 65% upside to the stock's last close

Stifel thinks PVLA has the potential to build a portfolio of rare skin disease treatments, "which collectively could have multi-billion-dollar potential"

Stifel notes co's gel QTORIN optimizes for delivery of the treatment into the deepest regions of the skin with potency and high patient tolerability

Including session's moves, PVLA stock more than doubled YTD

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Recommended Articles

Micron Surges 9% to Record High as Nasdaq Hits 10-Day Winning Streak: Will Memory Stocks Lead the Bull Market’s Return?

TradingKey - At the U.S. market close on April 14, the Nasdaq completed a 10-day winning streak, marking its longest since 2021; NVIDIA (NVDA) , AMD also recorded 10-day winning streaks. Micron (MU) surged 9% to a new closing high, leading the U.S. chip sector. The Philadelphia Semiconductor Index r

Anthropic IPO vs OpenAI IPO: Can an $800 Billion Valuation Help Anthropic Claim the First Large Model Stock?

TradingKey – An $800 billion valuation for Anthropic: this is the most staggering figure in the global AI investment circle as of April 2026. According to Business Insider, several venture capital firms have proactively extended investment offers to Claude developer Anthropic, with valuations reaching up to $800 billion—double the $380 billion valuation from its Series G round just two months prior. Notably, Anthropic has yet to accept any new funding, despite Silicon Valley capital vying for a stake. With the company set to launch its IPO as early as October 2026, the battle for the title of "the first public LLM stock" between the Anthropic IPO and the OpenAI IPO has officially begun.

Software Stocks Are Continuing to Rebound, Should Investors Buy Oracle or Microsoft Now?

TradingKey - Following a 12.7% single-day surge in Oracle's (ORCL.US) share price on April 13, which added $50.4 billion to its market capitalization, the stock extended its rally on April 14, rising another 4.74% to $163, as trading volume expanded to $9.783 billion.

Gold Price Stands Strongly Above $4,800, Can It Return to $5,000 This Time?

TradingKey - Gold prices (XAUUSD) hit new highs today (April 15), with spot gold briefly rising to $4,871.31 per ounce, reclaiming the $4,800 level, while U.S. gold futures approached $4,900. This rally was primarily driven by a weakening U.S. dollar and a recovery in risk appetite following expecta

ASML 2026 Q1 Earnings Preview: Valuations Are Already at Highs, Can AI Orders Support Growth Expectations?

TradingKey - Global lithography leader ASML is set to disclose its first-quarter 2026 financial results on April 15. Market focus on the company's short-term performance volatility and long-term growth potential continues to intensify.

Featured Tools